Iwabuchi Ikuya, Mori Kazuyuki, Yamamoto Hayato, Hatakeyama Shingo, Yoneyama Takahiro, Hashimoto Yasuhiro, Koie Takuya, Kamimura Noritaka, Suzuki Tadashi, Ohyama Chikara
The Department of Urology, Hirosaki University Graduate School of Medicine, Japan.
Hinyokika Kiyo. 2010 Oct;56(10):551-7.
We developed a simple urine telomerase activity assay by a modification of the TeloTAGGG telomerase polymerase chain reaction (PCR) enzyme-linked immunosorbent assay kit. We conjugated digoxygenin (DIG) with the CX primer of omitting hybridization of PCR products and DIG-labeled probe. The sensitivity and specificity of bladder cancer diagnosis on 100 patients with bladder cancer and 25 healthy volunteers using the simple urine telomerase activity measurement were 81% and 92%, respectively. The positive rate for bladder cancer by the present assay system was affected by neither tumor grade nor invasiveness. The diagnostic potential of the present method is superior to the conventional urine telomerase assay kit and urine nuclear matrix protein-22 (NMP22). The present method is simple, and can be used for mass screening of bladder cancer.
我们通过对TeloTAGGG端粒酶聚合酶链反应(PCR)酶联免疫吸附测定试剂盒进行改良,开发了一种简单的尿液端粒酶活性检测方法。我们将地高辛(DIG)与省略了PCR产物杂交和DIG标记探针的CX引物进行偶联。使用这种简单的尿液端粒酶活性检测方法,对100例膀胱癌患者和25名健康志愿者进行膀胱癌诊断的敏感性和特异性分别为81%和92%。本检测系统对膀胱癌的阳性率不受肿瘤分级和侵袭性的影响。本方法的诊断潜力优于传统的尿液端粒酶检测试剂盒和尿液核基质蛋白-22(NMP22)。本方法操作简单,可用于膀胱癌大规模筛查。